Using a claims data-based sentinel system to improve compliance with clinical guidelines: Results of a randomized prospective study

American Journal of Managed Care

Volumn 11, Issue 2, 2005, Pages 93-102

  Javitt, Jonathan C ^a,b,e   Steinberg, Gregory ^a   Locke, Todd ^c   Couch, James B ^d   Jacques, Jeffrey ^a   Juster, Iver ^a   Reisman, Lonny ^a  

^a ActiveHealth Management   (United States)

^b POTOMAC INSTITUTE FOR POLICY STUDIES   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d American Re Insurance Company   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL PRACTICE; MORBIDITY; PATIENT COMPLIANCE; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ARTIFICIAL INTELLIGENCE; DECISION SUPPORT SYSTEMS, CLINICAL; FEMALE; GUIDELINE ADHERENCE; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE CLAIM REVIEW; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; MIDWESTERN UNITED STATES; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES; PROSPECTIVE STUDIES; SENTINEL SURVEILLANCE;

EID: 13844312850     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Institute of Medicine, Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
2. President's Information Technology Advisory Committee. Report to the President: Transforming Health Care Through information Technology. Arlington, Va: National Coordination Office for Information Technology Research and Development; 2001.
3. Institute of Medicine. Key Capabilities of an Electronic Health Record. Washington, DC: National Academy Press; July 31, 2003.
4. Evans RS, Pestotnik SL, Classen DC, et al. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med. 1998;338:232-238.
5. Rind DM, Safran C, Phillips RS, et al. Effect of computer-based alerts on the treatment and outcomes of hospitalized patients. Arch Intern Med. 1994;154:1511-1517.
6. Hunt DL, Hanes RB, Hanna SE, Smith K. Effects of computer-based clinical decision support systems on physician performance and patient outcomes. JAMA. 1998;280:1339-1346.
7. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 1991;325:293-302.
8. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure, I: asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.
9. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med. 1987;316:1429-1435.
10. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G; Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published corrections appear in N Engl J Med. 2000;342:748 and N Engl J Med. 2000;342:1376]. N Engl J Med. 2000;342:145-153.
11. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G; Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published corrections appear in N Engl J Med. 2000;342:748 and N Engl J Med. 2000;342:1376]. N Engl J Med. 2000;342:145-153.
12. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G; Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published corrections appear in N Engl J Med. 2000;342:748 and N Engl J Med. 2000;342:1376]. N Engl J Med. 2000;342:145-153.
13. beta-Blocker Heart Attack Study Group. A randomized trial of propranolol in patients with acute myocardial infarction, I: mortality results. JAMA. 1982;247:1707-1714.
14. beta-Blocker Heart Attack Study Group. A randomized trial of propranolol in patients with acute myocardial infarction, II: morbidity results. JAMA. 1983;250: 2814-2819.
15. Ezekowitz MD, Levine JA. Preventing stroke in patients with atrial fibrillation. JAMA. 1999;281:1830-1835.
16. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154:1449-1457.
17. Physicians' Desk Reference. 57th ed. Montvale, NJ: Thompson Publishing Company; 2003:645, 995, 1473, 2510, 3180.
18. Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C; American College of Cardiology; American Heart Association; National Heart, Lung, and Blood Institute. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol. 2002;40:567-572.
19. American Diabetes Association. Position statement: standards of medical care for patients with diabetes mellitus. Diabetes Care. 2002;25(suppl 1):S33-S49.
20. Bailey CJ, Turner RC. Metformin. N Engl J Med. 1996;334:574-579.
21. American College of Chest Physicians. Proceedings of the American College of Chest Physicians 5th Consensus on Antithrombotic Therapy: 1998. Chest. 1998; 114(suppl):439S-769S.
22. Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344: 410-417.
23. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-442.
24. National Institutes of Health. Guidelines for the Diagnosis and Management of Asthma: Expert Panel Report 2. Bethesda, Md: National Heart, Lung, and Blood Institute, Public Health Service, US Dept of Health and Human Services; 1997.
25. National Institutes of Health. Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement. 2000;17:1-45.
26. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum. 2001;44: 1496-1503.
27. Wood AJ. Adverse reactions to drugs. In: Braunwald E, Fauci AS, Kasper DL, et al, eds. Harrison's Textbook of Internal Medicine. 15th ed. Philadelphia, Pa: CBS Saunders Publishers Inc; 2001:436.
28. Brown BC, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583-1592.
29. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
30. Younossi ZM. Viral hepatitis guide for practicing physicians: Cleveland Clinic Medicine. Cleve Clin J Med. 2000;67(suppl 1):S16-S45.
31. Gaspoz JM, Coxson PG, Goldman PA, et al. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med. 2002;346:1800-1806.
32. Whiteman T, Hassouna HI. Hypercoagulable states. Hematol Oncol Clin North Am. 2000;2:355-377, viii.
33. Hunt SA, Baker DW, Chin MH, et al; American College of Cardiology/American Heart Association. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001;38:2101-2113.
34. Fuster V, Ryden LE, Asinger RW, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation); North American Society of Pacing and Electrophysiology. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation. 2001;104:2118-2150.
35. Koudstaal PJ. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks. Cochrane Database Syst Rev. 2000:CD000185.
36. President's Information Technology Advisory Committee. Revolutionizing Health Care Through Information Technology. Arlington, Va: National Coordination Office; 2004.